Abstract
Prostaglandins are among the most important natural isolates owing to their broad range of bioactivities and unique structures. However, current methods for the synthesis of prostaglandins suffer from low yields and lengthy steps. Here, we report a practicability-oriented synthetic strategy for the enantioselective and divergent synthesis of prostaglandins. In this approach, the multiply substituted five-membered rings in prostaglandins were constructed via the key enyne cycloisomerization with excellent selectivity (>20:1 d.r., 98% e.e.). The crucial chiral centre on the scaffold of the prostaglandins was installed using the asymmetric hydrogenation method (up to 98% yield and 98% e.e.). From our versatile common intermediates, a series of prostaglandins and related drugs could be produced in two steps, and fluprostenol could be prepared on a 20-gram scale.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
Crystallographic data for the structures reported in this Article have been deposited at the Cambridge Crystallographic Data Centre, under deposition no. CCDC 2013314 (compound 21). Copies of the data can be obtained free of charge via https://www.ccdc.cam.ac.uk/structures/. The experimental procedures and characterization of all new compounds are provided in the Supplementary Information. All other data supporting the findings of this study are available within this Article and its Supplementary Information.
References
Gibson, K. H. Prostaglandins, thromboxanes, PGX: biosynthetic products from arachidonic acid. Chem. Soc. Rev. 6, 489–510 (1977).
Curtis-Prior, P. B. Prostaglandins: Biology and Chemistry of Prostaglandins and Related Eicosanoids (Churchill Livingstone, 1988).
Marks, F. & Fürstenberger, G. Prostaglandins, Laukotrienes and Other Eicosanoids (Wiley, 1999).
Dams, I., Wasyluk, J., Prost, M. & Kutner, A. Therapeutic uses of prostaglandin F2α analogues in ocular disease and novel synthetic strategies. Prostaglandins Other Lipid Mediat. 104–105, 109–121 (2013).
Peng, H. & Chen, F. E. Recent advances in asymmetric total synthesis of prostaglandins. Org. Biomol. Chem. 15, 6281–6301 (2017).
Das, S., Chandrasekhar, S., Yadav, J. S. & Gree, R. Recent developments in the synthesis of prostaglandins and analogues. Chem. Rev. 107, 3286–3337 (2007).
Li, J. J. in Name Reactions: A Collection of Detailed Mechanisms and Synthetic Applications (ed. Li, J. J.) 652–653 (Springer, 2014).
Cao, P., Wang, B. & Zhang, X. Rh-catalyzed enyne cycloisomerization. J. Am. Chem. Soc. 122, 6490–6491 (2000).
Wu, W. et al. Asymmetric hydrogenation of α-hydroxy ketones with an iridium/f-amphox catalyst: efficient access to chiral 1,2-diols. Org. Chem. Front. 4, 555–559 (2017).
Von Euler, U. S. Information on the pharmacological effect of natural secretions and extracts from male accessory sexual glands. Arch. Exp. Pathol. Pharm. 175, 78–84 (1934).
Bergström, S. et al. The isolation of prostaglandin. Acta Chem. Scand. 11, 1086–1086 (1957).
Flower, R. J. Prostaglandins, bioassay and inflammation. Br. J. Pharmacol. 147, 182–192 (2006).
Bergström, S. Prostaglandins: members of a new hormonal system. These physiologically very potent compounds of ubiquitous occurrence are formed from essential fatty acids. Science 157, 382–391 (1967).
Funk, C. D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294, 1871–1875 (2001).
Corey, E. J., Weinshenker, N. M., Schaaf, T. K. & Huber, W. Stereo-controlled synthesis of dl-prostaglandins F2α and E2. J. Am. Chem. Soc. 91, 5675–5677 (1969).
Woodward, R. B. et al. Novel synthesis of prostaglandin F2α. J. Am. Chem. Soc. 95, 6853–6855 (1973).
Stork, G. & Isobe, M. General approach to prostaglandins via methylenecyclopentanones. Total synthesis of (±)-prostaglandin F2α. J. Am. Chem. Soc. 97, 4745–4746 (1975).
Suzuki, M., Yanagisawa, A. & Noyori, R. An extremely short way to prostaglandins. J. Am. Chem. Soc. 107, 3348–3349 (1985).
Danishefsky, S. J., Paz Cabal, M. & Chow, K. Novel stereospecific silyl group transfer reactions: practical routes to the prostaglandins. J. Am. Chem. Soc. 111, 3456–3457 (1989).
Coulthard, G., Erb, W. & Aggarwal, V. K. Stereocontrolled organocatalytic synthesis of prostaglandin PGF2α in seven steps. Nature 489, 278–281 (2012).
Edwards, J. T. et al. Decarboxylative alkenylation. Nature 545, 213–218 (2017).
Li, J., Ahmed, T. S., Xu, C., Stoltz, B. M. & Grubbs, R. H. Concise syntheses of Δ12-prostaglandin J natural products via stereoretentive metathesis. J. Am. Chem. Soc. 141, 154–158 (2019).
Zhu, K., Hu, S., Liu, M., Peng, H. & Chen, F.-E. Access to a key building block for the prostaglandin family via stereocontrolled organocatalytic Baeyer–Villiger oxidation. Angew. Chem. Int. Ed. 58, 9923–9927 (2019).
Sheddan, N. A. & Mulzer, J. Cross metathesis as a general strategy for the synthesis of prostacyclin and prostaglandin analogues. Org. Lett. 8, 3101–3104 (2006).
Sih, C. J. et al. Total synthesis of prostaglandins. II. Prostaglandin E1. J. Am. Chem. Soc. 94, 3643–3644 (1972).
Umekubo, N., Suga, Y. & Hayashi, Y. Pot and time economies in the total synthesis of Corey lactone. Chem. Sci. 11, 1205–1209 (2020).
Xu, C., Shen, X. & Hoveyda, A. H. In situ methylene capping: a general strategy for efficient stereoretentive catalytic olefin metathesis. The concept, methodological implications and applications to synthesis of biologically active compounds. J. Am. Chem. Soc. 139, 10919–10928 (2017).
Monteiro, S., Paraskevopoulos, G. & Imramovský, A. Synthesis of 13,14-dehydro-prostaglandins synthetic analogues: a review. ChemistrySelect 4, 11247–11255 (2019).
Nair, S. K. & Henegar, K. E. in Modern Drug Synthesis (eds Li, J. J. & Johnson, D. S.) 329–338 (Wiley, 2010).
Pelss, A. et al. Reoptimization of the organocatalyzed double aldol domino process to a key enal intermediate and its application to the total synthesis of Δ12-prostaglandin J3. Chem. Eur. J. 24, 9542–9545 (2018).
Aubert, C., Buisine, O. & Malacria, M. The behavior of 1,n-enynes in the presence of transition metals. Chem. Rev. 102, 813–834 (2002).
Acknowledgements
X.Z. is indebted to the Southern University of Science and Technology (start-up fund), Shenzhen Science and Technology Innovation Committee (grant no. KQTD20150717103157174), Shenzhen Nobel Prize Scientists Laboratory Project (C17783101), Key-Area Research and Development Program of Guangdong Province (grant no. 2020B010188001), Innovative Team of Universities in Guangdong Province (grant no. 2020KCXTD016) and National Natural Science Foundation of China (grant no. 21991113). G.-Q.C. gratefully acknowledges the Youth Fund from the National Natural Science Foundation of China (grant no. 21901107).
Author information
Authors and Affiliations
Contributions
F.Z. contributed to the conception and design of the experiments. F.Z. performed the experiments and analysed the data. F.Z. and J.Z. conducted the gram-scale preparation of fluprostenol. M.G. and L.W. synthesized several intermediates. Y.L. provided useful advice in the synthesis of PGE. F.Z. and G.-Q.C. co-wrote the manuscript. X.Z. and G.-Q.C. conceived and directed the investigations and composed the manuscript, with revisions provided by F.Z.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Peer review information Nature Chemistry thanks Fener Chen and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Information
Characterization data, supplementary experimental data, synthetic procedures, Supplementary Figs. 1–7 and Tables 1–16.
Supplementary Data 1
Crystallographic data for compound 21. CCDC reference 2013314.
Supplementary Data 2
Structure factors file for compound 21. CCDC reference 2013314.
Rights and permissions
About this article
Cite this article
Zhang, F., Zeng, J., Gao, M. et al. Concise, scalable and enantioselective total synthesis of prostaglandins. Nat. Chem. 13, 692–697 (2021). https://doi.org/10.1038/s41557-021-00706-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41557-021-00706-1
This article is cited by
-
A concise and scalable chemoenzymatic synthesis of prostaglandins
Nature Communications (2024)
-
Structures of human prostaglandin F2α receptor reveal the mechanism of ligand and G protein selectivity
Nature Communications (2023)